Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAHORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XAHORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XAHSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAHSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XAHEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.5ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.5.2.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.5SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.25.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.25.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.25.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.25.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.25.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.25.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XADORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XADORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XADSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XADSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XADEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XADEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XADNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XADNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XABORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XABORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XABSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XABSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XABEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XABEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XABNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XABNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
CH.1.1.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CH.1.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CH.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FT.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FT.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used